The cytosolic DNA-sensing cGAS-STING pathway in neurodegenerative diseases

CNS Neurosci Ther. 2024 Mar;30(3):e14671. doi: 10.1111/cns.14671.

Abstract

Background: With the widespread prevalence of neurodegenerative diseases (NDs) and high rates of mortality and disability, it is imminent to find accurate targets for intervention. There is growing evidence that neuroimmunity is pivotal in the pathology of NDs and that interventions targeting neuroimmunity hold great promise. Exogenous or dislocated nucleic acids activate the cytosolic DNA sensor cyclic GMP-AMP synthase (cGAS), activating the stimulator of interferon genes (STING). The activated STING triggers innate immune responses and then the cGAS-STING signaling pathway links abnormal nucleic acid sensing to the immune response. Recently, numerous studies have shown that neuroinflammation regulated by cGAS-STING signaling plays an essential role in NDs.

Aims: In this review, we summarized the mechanism of cGAS-STING signaling in NDs and focused on inhibitors targeting cGAS-STING.

Conclusion: The cGAS-STING signaling plays an important role in the pathogenesis of NDs. Inhibiting the cGAS-STING signaling may provide new measures in the treatment of NDs.

Keywords: STING; cGAS; innate immune; neurodegenerative diseases.

Publication types

  • Review

MeSH terms

  • DNA / genetics
  • DNA / metabolism
  • Humans
  • Immunity, Innate
  • Neurodegenerative Diseases* / genetics
  • Nucleotidyltransferases / genetics
  • Nucleotidyltransferases / metabolism
  • Signal Transduction / physiology

Substances

  • DNA
  • Nucleotidyltransferases
  • cGAS protein, human
  • STING1 protein, human